Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 15, 2006

Thermo Fisher Scientific Takes Over Cohesive Technologies

  • Thermo Fisher Scientific acquired Massachusetts-based Cohesive Technologies, a manufacturer of advanced sample extraction and liquid chromatography products.

    "Cohesive's sample-preparation technologies will strengthen our ability to offer customers the advanced tools they need to accelerate research and discovery and to provide them with higher-quality analytical information," said Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific.

    The Cohesive product line adds in-line sample-preparation capabilities that couple with mass spectrometry technology. These new capabilities will significantly improve sample throughput and increase detection limits during LC/MS/MS analysis for customers in the pharmaceutical, clinical, environmental, and food science industries, states Thermo Fisher Scientific.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »